Convert Hold to Underweight: technical trigger architecture has fired with price below $99 and 200 SMA, empirically confirmed alpha-bleed requires preemptive de-risk to 50–60% of neutral weight
Underweight with explicit triggers is the rating that survives every binding test: honors structural floor (8% capital return yield, 20.3% ROE, sub-1 PEG, $13.7B buyback program, NII runway locked by 96% no-cut pricing) while arresting the alpha-bleed pathology. The 9/21, 9/24, 9/28, 9/29, and 10/01 binding reflections are all honored. Underweight preserves the structural-support thesis without waiting for the $92 structural stop where alpha damage is already locked in. The next two sessions' price action determines whether Underweight sits at 60% (if price stabilizes above $97) or 50% (if price drifts to $96).
| Position | Action |
|---|---|
| Price stabilizes above $97 | Position at 60% of neutral benchmark weight |
| Price drifts to $96 | Position at 50% of neutral benchmark weight |
| Pre-earnings period (~2 weeks) | Trim incrementally rather than in one block |
SCHW presents a high-conviction buying opportunity where record-breaking fundamentals (20%+ ROE, 42.6% EPS growth, $7.07B Q2 revenue) are trading at a 30%+ discount to the S&P 500 (12.4x forward P/E, 0.83 PEG) near 52-week lows, with oversold technicals (RSI 30.52, MACD bullish divergence at 200-day SMA $97.84) and $13.7B annual buybacks providing a structural support floor.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 30.52 | bullish |
| MACD (12,26,9) | -2.47 | bearish |
| MACD Signal | -1.58 | bearish |
| MACD Histogram | -0.89 | bullish |
| 10 EMA | 100.74 | bearish |
| 50 SMA | 106.37 | bearish |
| 200 SMA | 97.84 | neutral |
| Bollinger Upper Band | 112.68 | neutral |
| Bollinger Middle Band | 104.32 | neutral |
| Bollinger Lower Band | 95.96 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$102.72 with MACD positive and volume >8M (10 EMA reclaim with confirmed momentum)
Then: Upgrade from Underweight to Hold
Q2 2026 earnings show accelerating fundamental growth across all key metrics
↩ rebuts: “Bear's implied fundamental weakness”
· concedes: MACD line hasn't turned yet, only the histogram; 10 EMA and 50 SMA are overhead resistance; Short-term momentum is broken; Tactical trading argument goes to the bear side
SCHW is in a confirmed bearish regime with NII likely at peak, multiple compression risk elevated, and technicals decisively bearish — making the stock more likely to test $90-93 than revisit $106 in the near term.
· concedes: 20.3% ROE and 12.4x forward P/E are real metrics; PEG of 0.83 suggests modest valuation premium; Deposit migration crisis of 2023 is 'ancient history'; SCHW has weathered 2023 crisis; Buybacks do provide some cushion during declines
→ vs conservative: MACD cross below zero on September 16 is misread as confirmed breakdown rather than bullish divergence; MACD line making lower lows while histogram making higher lows is classic accumulation signal, not distribution
→ vs conservative: Deposit beta and NII ceiling concern is '2023 mentality' — the aggressive Fed hiking cycle that forced re-pricing of zero-yield sweep deposits is dead; current hold regime makes the deposit franchise stable, not fragile
→ vs conservative: 'Lower highs, lower lows since August 26' is rearview mirror observation; entire financial sector was crushed pricing in hawkish Fed policy that has now flipped; market conditions have fundamentally changed
→ vs conservative: Waiting for 'confirmed reversal' at close above $106.37 on 12 million volume means missing 10% of the move at $108-$110
→ vs conservative: September 22 gap-down on 16.9 million volume was institutional accumulation by value-oriented institutions recognizing the PEG-0.83 setup, not institutional distribution — one day does not make a trend
→ vs neutral: Framing setup as symmetric is mathematically wrong; PEG below 1.0 at major technical support in a high-quality compounder with 40%+ earnings growth is inherently asymmetric, not symmetric
→ vs neutral: The 96% no-rate-cuts pricing is already fully in the stock (explains current $97.74 price versus fair value of $114); market has NOT digested Q3 earnings catalyst, asset management fee tailwind, or the closing of SCHW's 0.753 beta divergence in risk-on environment
→ vs neutral: Deposit beta normalization means current NII run rate is sustainable, not a ceiling — static thinking about rate cuts ignores normalization dynamics
| 2.25 |
| neutral |
| Current Close | 97.74 | neutral |
Support: 95.96 · 90.5 · 87.3 | Resistance: 100.74 · 106.37 · 112.68
SCHW technical analysis shows the stock at a critical juncture, testing 200-day SMA support ($97.84) after a sharp selloff from August highs near $114. The technical posture is decisively bearish across all major trends (price < 10 EMA < 50 SMA), but RSI near oversold (30.52) and MACD histogram higher-low divergence suggest downside momentum is decelerating. The report recommends HOLD for existing holders, with tactical bounce targets at $100.74 (10 EMA), $106.37 (50 SMA), and $112.68 (Bollinger Upper), while a breakdown below $95.96 (Bollinger Lower) would signal capitulation with downside targets at $93-$90 zone.
Market Cap
$167.23B
Share Price
~$96.71
52-Week High
$114.53
52-Week Low
$83.96
50-Day MA
$106.42
200-Day MA
$98.33
Beta
0.753
P/E (TTM)
17.6
Forward P/E
12.4
PEG Ratio
0.83
Price/Book
3.80x
EPS TTM
$5.49
Forward EPS
$7.83
Q2 2026 Revenue
$7.07B
Q2 2026 Net Interest Income
$3.36B
Q2 2026 Net Income
$2.80B
Q2 2026 Diluted EPS
$1.54
Q1 2026 Revenue
$6.48B
Q1 2026 Diluted EPS
$1.37
Q4 2025 Revenue
$6.34B
Q4 2025 Diluted EPS
$1.33
Q3 2025 Revenue
$6.14B
Q3 2025 Diluted EPS
$1.26
Q2 2025 Revenue
$5.85B
Q2 2025 Diluted EPS
$1.08
Interest Income
$4.15B
Interest Expense
$789M
SG&A
$1.90B
Tax Rate
23.7%
Profit Margin (TTM)
38.8%
Operating Margin (TTM)
52.3%
Total Assets
$517.27B
Total Liabilities
$467.12B
Total Equity
$50.15B
Common Stockholders Equity
$43.93B
Preferred Stock
$6.21B
Tangible Book Value
$24.36B
Book Value/Share
$25.42
Cash & Equivalents
$40.58B
Total Debt
$37.35B
Long-Term Debt
$22.88B
Held-to-Maturity Securities
$126.64B
Receivables
$144.85B
Cumulative Treasury Stock
$21.7B
Goodwill
$12.29B
ROE
20.3%
ROA
2.07%
OCF Q2 2026
$4.30B
FCF Q2 2026
$4.12B
OCF Q1 2026
$7.34B
FCF Q1 2026
$7.20B
OCF Q3 2025
$0.54B
FCF Q3 2025
$0.39B
OCF Q4 2025
-$0.76B
FCF Q4 2025
-$0.92B
OCF Q2 2025
$3.18B
FCF Q2 2025
$3.05B
Share Repurchases Q2 2026
$3.05B
Dividends Paid Q2 2026
$643M
CapEx Q2 2026
$185M
Net Debt Issuance
+$3.63B
Interest Paid
$1.06B
Taxes Paid
$1.70B
LTM Buybacks
$13.7B
LTM Dividends
$3.0B
Total Returned to Shareholders (5 Quarters)
$16.7B
Dividend Yield
1.3%
Debt/Equity Ratio
151x
Strengths
Concerns
EXCEPTIONAL — SCHW exhibits best-in-class profitability with 20.3% ROE, 38.8% net margin, and 52.3% operating margin, driven by strong NII recovery ($3.36B+ run-rate) and accelerating revenue growth (+20.9% YoY). Valuation appears attractive with forward P/E of 12.4x, PEG of 0.83, and stock trading near 52-week lows below the 50-day MA. Aggressive capital returns ($13.7B buybacks + $3.0B dividends over LTM) provide a strong floor for shareholder returns.
Macro: September jobs report missed expectations, easing Treasury yields and rallying equities — a goldilocks reaction. Fed rate-hike narrative fading as the dominant headline. Polymarket prices 96% no Fed cuts in 2026 ($8.73M volume), essentially a settled view with all higher-cut scenarios pricing at 0%. Recession odds at only 8% (Polymarket, $2.24M volume, -2.0pp on the week). ECB October 2026 prices 94% no change; BoE November 2026 prices 80% chance of +25bps hike — Fed is the dovish outlier globally. Iran war driving cost-push inflation beyond energy, which could force Fed to remain on hold rather than ease. No SCHW-specific news retrieved in the 7-day or 30-day windows.